RxNorm Semantic Concepts Index - 144
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "144".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 1440000 | miconazole Vaginal Cream [Lagicam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1440001 | Lagicam Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1440002 | lagicam 4 % Vaginal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440002 | lagicam 4 % Vaginal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440002 | lagicam 4 % Vaginal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440002 | lagicam 4 % Vaginal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1440003 | codeine phosphate 9 MG / dexchlorpheniramine maleate 1 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440003 | codeine phosphate 9 MG / dexchlorpheniramine maleate 1 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440003 | codeine phosphate 9 MG / dexchlorpheniramine maleate 1 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440004 | cod liver oil / petrolatum Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1440005 | cod liver oil / petrolatum Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1440006 | cod liver oil / petrolatum | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1440007 | petrolatum 30 % / cod liver oil 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1440007 | petrolatum 30 % / cod liver oil 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440007 | petrolatum 30 % / cod liver oil 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1440008 | petrolatum 507.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1440009 | Petrolatum 50.74 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440009 | Petrolatum 50.74 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 144001 | Hydroxyalprazolam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144001 | Hydroxyalprazolam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144001 | Hydroxyalprazolam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144001 | Hydroxyalprazolam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440015 | camphor 0.001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1440017 | Dove DermaSeries | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1440018 | dimethicone 60 MG/ML [Dove DermaSeries] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1440019 | dimethicone Topical Cream [Dove DermaSeries] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 144002 | Hydroxytriazolam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144002 | Hydroxytriazolam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440020 | Dove DermaSeries Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1440021 | Dove DermaSeries 6 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1440021 | Dove DermaSeries 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1440021 | Dove DermaSeries 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440021 | Dove DermaSeries 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440022 | Dove DermaSeries Eczema | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1440023 | colloidal oatmeal 10 MG/ML [Dove DermaSeries Eczema] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1440024 | colloidal oatmeal Topical Cream [Dove DermaSeries Eczema] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1440025 | Dove DermaSeries Eczema Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1440026 | Dove DermaSeries Eczema 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1440026 | Dove DermaSeries Eczema 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1440026 | Dove DermaSeries Eczema 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440026 | Dove DermaSeries Eczema 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440046 | lipegfilgrastim | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440046 | lipegfilgrastim | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1440046 | lipegfilgrastim | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440047 | lipegfilgrastim 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1440048 | lipegfilgrastim Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1440049 | lipegfilgrastim Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1440050 | lipegfilgrastim 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1440051 | Lixisenatide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440051 | Lixisenatide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440051 | Lixisenatide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440051 | Lixisenatide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440051 | Lixisenatide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440052 | lixisenatide 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1440053 | Lixisenatide-containing product in parenteral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1440053 | Lixisenatide-containing product in parenteral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440053 | Lixisenatide-containing product in parenteral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440056 | lixisenatide 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1440059 | magnesium salicylate 406 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1440060 | magnesium salicylate 406 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1440060 | magnesium salicylate 406 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1440061 | methyl salicylate 180 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1440062 | camphor / capsaicin / methyl salicylate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1440063 | camphor / capsaicin / methyl salicylate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1440064 | camphor / capsaicin / methyl salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1440065 | camphor 3.6 % / capsaicin 0.025 % / methyl salicylate 18 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440065 | camphor 3.6 % / capsaicin 0.025 % / methyl salicylate 18 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440065 | camphor 3.6 % / capsaicin 0.025 % / methyl salicylate 18 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 144007 | Norchlordiazepoxide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144007 | Norchlordiazepoxide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 14401 | 3-hydroxybenzoate 4-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 14401 | 3-hydroxybenzoate 4-hydroxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14401 | 3-hydroxybenzoate 4-hydroxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144010 | Phenylethylmalonate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144010 | Phenylethylmalonate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144015 | Albumin bound thyroxine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144015 | Albumin bound thyroxine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144018 | Alpha-1-fetoprotein antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144018 | Alpha-1-fetoprotein antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440180 | petrolatum 0.93 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1440181 | petrolatum 93 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440181 | petrolatum 93 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440181 | petrolatum 93 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440183 | LARIN Fe 1/20 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1440183 | LARIN Fe 1/20 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440183 | LARIN Fe 1/20 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440184 | hydrocortisone acetate 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440184 | hydrocortisone acetate 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440184 | hydrocortisone acetate 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440184 | hydrocortisone acetate 1 % Topical Ointment | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440184 | hydrocortisone acetate 1 % Topical Ointment | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440185 | Aubra 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1440185 | Aubra 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440185 | Aubra 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440185 | Aubra 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440187 | dimethicone 110 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1440188 | dimethicone 11 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1440188 | dimethicone 11 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440188 | dimethicone 11 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1440189 | dimethicone 110 MG/ML [Dove DermaSeries] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1440190 | dimethicone Topical Lotion [Dove DermaSeries] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1440191 | Dove DermaSeries 1.1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1440191 | Dove DermaSeries 1.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1440191 | Dove DermaSeries 1.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440191 | Dove DermaSeries 1.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 14402 | 3-hydroxybenzoate 6-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 14402 | 3-hydroxybenzoate 6-hydroxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14402 | 3-hydroxybenzoate 6-hydroxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144022 | Aspergillus flavus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144022 | Aspergillus flavus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440224 | Boswellia sacra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440225 | corn cob extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440226 | Ficus carica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440227 | zeatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440228 | hydrogenated methyl abietate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 144023 | Aspergillus glaucus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144023 | Aspergillus glaucus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440231 | myristamidopropyl PG-dimonium chloride phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440235 | PEG-8 glyceryl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440237 | PEG-80 sorbitan laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440239 | PPG-12/SMDI copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440241 | safflower seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440247 | hydrogenated rapeseed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440250 | hydrogenated didecene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440252 | hydrogenated avocado oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440254 | ethyl palmate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440257 | benzyl nicotinamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440261 | baicalin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440263 | aminopterin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1440264 | Aminopterin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440264 | Aminopterin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1440264 | Aminopterin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440266 | Aminometradine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440266 | Aminometradine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440266 | Aminometradine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440268 | aminopropazine fumarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440270 | amonafide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440271 | amoproxan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440278 | Platanus occidentalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440286 | Oxyuranus scutellatus canni venom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440287 | Crotalus durissus terrificus venom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440288 | sinapultide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440289 | Tripterygium wilfordii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440290 | ferrous carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440301 | loperamide / simethicone Chewable Tablet [Imodium Multi-Symptom Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1440302 | Imodium Multi-Symptom Relief Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1440303 | Imodium Multi-Symptom Relief 2 MG / 125 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1440303 | Imodium Multi-Symptom Relief 2 MG / 125 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1440303 | Imodium Multi-Symptom Relief 2 MG / 125 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 14405 | 3-hydroxybenzyl-alcohol dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14405 | 3-hydroxybenzyl-alcohol dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144051 | Brugia malayi antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144051 | Brugia malayi antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144052 | Cancer antigen DM /70K | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144052 | Cancer antigen DM /70K | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144062 | Complement SC5b-9 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144062 | Complement SC5b-9 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144065 | Cytokeratin antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144065 | Cytokeratin antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144070 | Anti-disialylganglioside GD1a antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144070 | Anti-disialylganglioside GD1a antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144070 | Anti-disialylganglioside GD1a antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144071 | Anti-disialylganglioside GD1b antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144071 | Anti-disialylganglioside GD1b antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144071 | Anti-disialylganglioside GD1b antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144075 | Ehrlichia chaffeensis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144075 | Ehrlichia chaffeensis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440856 | CA - Cholic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440857 | cholic acid 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1440858 | Cholic acid-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1440858 | Cholic acid-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1440858 | Cholic acid-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1440859 | cholic acid Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1440860 | cholic acid Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1440861 | cholic acid 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440861 | cholic acid 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440867 | cholic acid 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1440868 | cholic acid 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440868 | cholic acid 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440869 | hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440869 | hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440870 | Urimar Reformulated Oct 2013 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1440871 | hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG [Urimar Reformulated Oct 2013] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1440872 | hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urimar Reformulated Oct 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1440873 | Urimar Reformulated Oct 2013 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1440874 | Urimar Reformulated Oct 2013 Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1440875 | URIMAR-T 120 MG / 40.8 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Oct 2013 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1440875 | URIMAR-T 120 MG / 40.8 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Oct 2013 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440875 | URIMAR-T 120 MG / 40.8 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Oct 2013 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440908 | dextromethorphan HBr 7.5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440908 | dextromethorphan HBr 7.5 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440919 | activated charcoal 30 GM Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440919 | activated charcoal 30 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440919 | activated charcoal 30 GM Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1440934 | hydrocortisone Topical Cream [Proctozone HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1440935 | Proctozone HC Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1440936 | Proctozone HC 2.5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1440936 | Proctozone HC 2.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440936 | Proctozone HC 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440936 | Proctozone HC 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440937 | LARIN Fe 1.5/30 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1440937 | LARIN Fe 1.5/30 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1440937 | LARIN Fe 1.5/30 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1440970 | 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1440971 | 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440972 | anazolene acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440973 | casein, Lactococcus lactis cultured, Penicillium roqueforti cultured, aged | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1440974 | Casein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1440974 | Casein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440974 | Casein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1440974 | Casein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1440974 | Casein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1440975 | zinc gluconate trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 144107 | HIV 1 gp105 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144107 | HIV 1 gp105 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144107 | HIV 1 gp105 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144108 | HIV 1 gp34 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144108 | HIV 1 gp34 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144108 | HIV 1 gp34 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144109 | HIV 1 p15 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144109 | HIV 1 p15 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144109 | HIV 1 p15 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 14411 | 3-hydroxydecanoyl-[acyl-carrier-protein]-dehydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14411 | 3-hydroxydecanoyl-[acyl-carrier-protein]-dehydratase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144110 | HIV 1 p18 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144110 | HIV 1 p18 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144110 | HIV 1 p18 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144111 | HIV 1 p23 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144111 | HIV 1 p23 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144111 | HIV 1 p23 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441111 | menthol 16 % / methyl salicylate 28 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441111 | menthol 16 % / methyl salicylate 28 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441111 | menthol 16 % / methyl salicylate 28 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441112 | salicylic acid 1.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441112 | salicylic acid 1.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441112 | salicylic acid 1.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441112 | salicylic acid 1.5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 144112 | HIV 1 p26 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144112 | HIV 1 p26 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144112 | HIV 1 p26 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144113 | HIV 1 p28 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144113 | HIV 1 p28 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144113 | HIV 1 p28 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144114 | HIV 1 p32 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144114 | HIV 1 p32 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144114 | HIV 1 p32 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144115 | HIV 1 p53 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144115 | HIV 1 p53 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144115 | HIV 1 p53 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144116 | HIV 1 p58 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144116 | HIV 1 p58 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144116 | HIV 1 p58 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144117 | HIV 1 p64 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144117 | HIV 1 p64 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144117 | HIV 1 p64 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441176 | allantoin / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1441177 | allantoin / zinc oxide Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1441178 | allantoin / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1441179 | allantoin 1 % / zinc oxide 25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441179 | allantoin 1 % / zinc oxide 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441179 | allantoin 1 % / zinc oxide 25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 144118 | HIV 1 p65 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144118 | HIV 1 p65 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144118 | HIV 1 p65 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441185 | hydrocortisone acetate 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441185 | hydrocortisone acetate 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441185 | hydrocortisone acetate 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441186 | isodecyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441187 | Lactobacillus acidophilus Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441188 | Lactobacillus acidophilus Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1441189 | Lactobacillus acidophilus 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441189 | Lactobacillus acidophilus 1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 144120 | HIV 2 gp125 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144120 | HIV 2 gp125 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144120 | HIV 2 gp125 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144121 | HIV 2 gp36 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144121 | HIV 2 gp36 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144121 | HIV 2 gp36 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144122 | HIV 2 gp80 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144122 | HIV 2 gp80 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144122 | HIV 2 gp80 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144123 | HIV 2 p26 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144123 | HIV 2 p26 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144123 | HIV 2 p26 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441232 | melatonin 1.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441233 | melatonin 3.5 MG per 2 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441233 | melatonin 3.5 MG per 2 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144125 | HIV 2 p56 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144125 | HIV 2 p56 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144125 | HIV 2 p56 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144126 | HIV 2 p68 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144126 | HIV 2 p68 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144126 | HIV 2 p68 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441273 | {1 (236 ML) (acetaminophen 21.7 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.25 MG/ML Oral Solution) / 20 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1441294 | Acalypha indica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441295 | Aconitum lycoctonum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441295 | Aconitum lycoctonum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441296 | Agave tequilana top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441297 | Agaricus campestris var. campestris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441298 | Amanita pantherina whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441299 | Amanita phalloides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441300 | camphor 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441301 | camphor / methyl salicylate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1441302 | camphor / methyl salicylate Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1441303 | camphor / methyl salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1441304 | camphor 7 % / methyl salicylate 15 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441304 | camphor 7 % / methyl salicylate 15 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441304 | camphor 7 % / methyl salicylate 15 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441305 | menthol 65 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441306 | methyl salicylate 260 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441307 | camphor 10 % / menthol 6.5 % / methyl salicylate 26 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441307 | camphor 10 % / menthol 6.5 % / methyl salicylate 26 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441307 | camphor 10 % / menthol 6.5 % / methyl salicylate 26 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441309 | camphor 90 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441310 | camphor 9 % / menthol 11 % / methyl salicylate 17 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441310 | camphor 9 % / menthol 11 % / methyl salicylate 17 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441310 | camphor 9 % / menthol 11 % / methyl salicylate 17 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441314 | Lansinoh Baby | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1441315 | dimethicone 0.05 MG/MG / lanolin 0.155 MG/MG / zinc oxide 0.055 MG/MG [Lansinoh Baby] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1441316 | dimethicone / lanolin / zinc oxide Topical Ointment [Lansinoh Baby] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441317 | Lansinoh Baby Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1441318 | Lansinoh baby 5 % / 15.5 % / 5.5 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441318 | Lansinoh baby 5 % / 15.5 % / 5.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441318 | Lansinoh baby 5 % / 15.5 % / 5.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441318 | Lansinoh baby 5 % / 15.5 % / 5.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 144132 | Legionella non-pneumophila species antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144132 | Legionella non-pneumophila species antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441320 | glycerin 613 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441321 | glycerin 12.5 GM per 20.4 mL Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441321 | glycerin 12.5 GM per 20.4 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441321 | glycerin 12.5 GM per 20.4 mL Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441322 | Iresine calea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441338 | vitamin B6 0.338 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441339 | melatonin 2.5 MG / vitamin B6 0.338 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441339 | melatonin 2.5 MG / vitamin B6 0.338 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441339 | melatonin 2.5 MG / vitamin B6 0.338 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441364 | dextromethorphan HBr 10 MG / guaiFENesin 187 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441364 | dextromethorphan HBr 10 MG / guaiFENesin 187 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441364 | dextromethorphan HBr 10 MG / guaiFENesin 187 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1441364 | dextromethorphan HBr 10 MG / guaiFENesin 187 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441364 | dextromethorphan HBr 10 MG / guaiFENesin 187 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1441368 | thiamine mononitrate 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441369 | thiamine mononitrate 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441369 | thiamine mononitrate 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441369 | thiamine mononitrate 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441369 | thiamine mononitrate 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441371 | ascorbic acid 120 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441371 | ascorbic acid 120 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441371 | ascorbic acid 120 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441371 | ascorbic acid 120 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441372 | chlophedianol / dexbrompheniramine / pseudoephedrine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441373 | chlophedianol / dexbrompheniramine / pseudoephedrine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441374 | chlophedianol / dexbrompheniramine / pseudoephedrine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1441375 | chlophedianol / dexbrompheniramine / pseudoephedrine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1441376 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441376 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441376 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441376 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441376 | chlophedianol HCl 12.5 MG / dexbrompheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441377 | Bacillus coagulans 1000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441378 | inulin 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441379 | Bacillus coagulans / inulin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441380 | Bacillus coagulans / inulin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441381 | Bacillus coagulans / inulin Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1441382 | Bacillus coagulans / inulin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1441383 | Bacillus coagulans 1 Billion UNT / inulin 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441383 | Bacillus coagulans 1 Billion UNT / inulin 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441383 | Bacillus coagulans 1 Billion UNT / inulin 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441383 | Bacillus coagulans 1 Billion UNT / inulin 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441384 | calcium carbonate 425 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441385 | calcium carbonate 425 MG (Ca 170 MG) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441385 | calcium carbonate 425 MG (Ca 170 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441385 | calcium carbonate 425 MG (Ca 170 MG) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441386 | Bazedoxifene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1441386 | Bazedoxifene | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1441386 | Bazedoxifene | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1441386 | Bazedoxifene | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1441386 | Bazedoxifene | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1441387 | bazedoxifene 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441388 | bazedoxifene / estrogens, conjugated (USP) Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441388 | bazedoxifene / estrogens, conjugated (USP) Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1441388 | bazedoxifene / estrogens, conjugated (USP) Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1441389 | bazedoxifene / estrogens, conjugated (USP) Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441390 | bazedoxifene / estrogens, conjugated (USP) Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1441391 | bazedoxifene / estrogens, conjugated (USP) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1441391 | bazedoxifene / estrogens, conjugated (USP) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1441391 | bazedoxifene / estrogens, conjugated (USP) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1441392 | estrogens, conjugated 0.45 MG / bazedoxifene acetate 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441392 | estrogens, conjugated 0.45 MG / bazedoxifene acetate 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441392 | estrogens, conjugated 0.45 MG / bazedoxifene acetate 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441393 | collagen 740 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441394 | ascorbic acid / collagen Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441395 | ascorbic acid / collagen Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441396 | ascorbic acid / collagen Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1441397 | ascorbic acid / collagen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1441398 | ascorbic acid 50 MG / collagen 740 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441398 | ascorbic acid 50 MG / collagen 740 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441398 | ascorbic acid 50 MG / collagen 740 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441398 | ascorbic acid 50 MG / collagen 740 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441399 | Russula emetica preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 144140 | Liver cytosol antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144140 | Liver cytosol antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441400 | Vitex agnus-castus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441402 | methotrexate 10 MG in 0.4 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441402 | methotrexate 10 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441402 | methotrexate 10 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441403 | Otrexup | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1441404 | methotrexate 25 MG/ML [Otrexup] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1441406 | Otrexup Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1441407 | Otrexup 10 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441407 | Otrexup 10 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441407 | Otrexup 10 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441407 | Otrexup 10 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441407 | Otrexup 10 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441408 | methotrexate 25 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441409 | methotrexate 25 MG/ML Auto-Injector [Otrexup] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441409 | methotrexate 25 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441409 | methotrexate 25 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441410 | methotrexate 37.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441411 | methotrexate 15 MG in 0.4 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441411 | methotrexate 15 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441411 | methotrexate 15 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441412 | methotrexate 37.5 MG/ML [Otrexup] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1441413 | Otrexup 15 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441413 | Otrexup 15 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441413 | Otrexup 15 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441413 | Otrexup 15 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441413 | Otrexup 15 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441414 | methotrexate 37.5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441415 | methotrexate 37.5 MG/ML Auto-Injector [Otrexup] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441415 | methotrexate 37.5 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441415 | methotrexate 37.5 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441416 | methotrexate 20 MG in 0.4 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441416 | methotrexate 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441416 | methotrexate 20 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441416 | methotrexate 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441417 | methotrexate 50 MG/ML [Otrexup] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1441418 | Otrexup 20 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441418 | Otrexup 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441418 | Otrexup 20 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441418 | Otrexup 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441418 | Otrexup 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441419 | methotrexate 50 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441420 | methotrexate 50 MG/ML Auto-Injector [Otrexup] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441420 | methotrexate 50 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441420 | methotrexate 50 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441421 | methotrexate 62.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441422 | methotrexate 25 MG in 0.4 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441422 | methotrexate 25 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441422 | methotrexate 25 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441423 | methotrexate 62.5 MG/ML [Otrexup] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1441424 | Otrexup 25 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441424 | Otrexup 25 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441424 | Otrexup 25 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441424 | Otrexup 25 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441424 | Otrexup 25 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441425 | methotrexate 62.5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441426 | methotrexate 62.5 MG/ML Auto-Injector [Otrexup] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441426 | methotrexate 62.5 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441426 | methotrexate 62.5 MG/ML Auto-Injector [Otrexup] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441428 | agaric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441525 | tocilizumab 180 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441526 | tocilizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1441527 | tocilizumab 162 MG in 0.9 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441527 | tocilizumab 162 MG in 0.9 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441527 | tocilizumab 162 MG in 0.9 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441528 | tocilizumab 180 MG/ML [Actemra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1441529 | tocilizumab Prefilled Syringe [Actemra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441530 | Actemra 162 MG in 0.9 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441530 | Actemra 162 MG in 0.9 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441530 | Actemra 162 MG in 0.9 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441531 | tocilizumab 180 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441532 | tocilizumab 180 MG/ML Prefilled Syringe [Actemra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441532 | tocilizumab 180 MG/ML Prefilled Syringe [Actemra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441533 | iodine 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441533 | iodine 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441533 | iodine 0.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441534 | polyethylene oxide 900000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1441534 | polyethylene oxide 900000 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441535 | sodium laureth-2 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1441536 | Allium sativum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441543 | black alder bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441543 | black alder bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441544 | Alstonia constricta bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441545 | ammonium valerate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441546 | aniline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441549 | Derma Gran | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1441550 | aluminum hydroxide 0.00275 MG/MG [Derma Gran] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1441551 | aluminum hydroxide Topical Ointment [Derma Gran] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441552 | Derma Gran Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1441553 | DERMA GRAN 0.275 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441553 | DERMA GRAN 0.275 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441553 | DERMA GRAN 0.275 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441553 | DERMA GRAN 0.275 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441556 | allantoin 0.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441556 | allantoin 0.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441556 | allantoin 0.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441557 | zinc pyrithione 7.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441558 | zinc pyrithione 0.75 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441558 | zinc pyrithione 0.75 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441558 | zinc pyrithione 0.75 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441559 | Head & Shoulders Damage Treatment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1441560 | zinc pyrithione 7.5 MG/ML [Head & Shoulders Damage Treatment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1441561 | zinc pyrithione Medicated Shampoo [Head & Shoulders Damage Treatment] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441562 | Head & Shoulders Damage Treatment Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1441563 | head & shoulders Damage Treatment 0.75 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441563 | head & shoulders Damage Treatment 0.75 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441563 | head & shoulders Damage Treatment 0.75 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441563 | head & shoulders Damage Treatment 0.75 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441565 | digoxin 187.5 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1441565 | digoxin 187.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441565 | digoxin 187.5 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441565 | digoxin 187.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441567 | LANOXIN 187.5 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441567 | LANOXIN 187.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441567 | LANOXIN 187.5 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441567 | LANOXIN 187.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 144157 | Antigen of Parainfluenza virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144157 | Antigen of Parainfluenza virus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144157 | Antigen of Parainfluenza virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144157 | Antigen of Parainfluenza virus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144158 | Parathyroid hormone antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144158 | Parathyroid hormone antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144158 | Parathyroid hormone antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441649 | d-alpha-tocopheryl acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1441650 | leptin human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1441651 | Leptin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441651 | Leptin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1441651 | Leptin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441652 | wheat preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441653 | zinc pyrithione 1 % Medicated Shampoo (10 ML) / zinc pyrithione 0.5 % Medicated Conditioner (10 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1441653 | zinc pyrithione 1 % Medicated Shampoo (10 ML) / zinc pyrithione 0.5 % Medicated Conditioner (10 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441654 | Head & Shoulders Dual Sachets Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1441654 | Head & Shoulders Dual Sachets Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441654 | Head & Shoulders Dual Sachets Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441654 | Head & Shoulders Dual Sachets Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441655 | Cervus elaphus velvet preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441656 | Trichomonas vaginalis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441657 | Mirabilis jalapa top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441658 | Senna occidentalis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441659 | sodium oxalate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1441660 | oxalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441664 | Aconitine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1441664 | Aconitine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1441664 | Aconitine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441683 | povidone 2 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441683 | povidone 2 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441683 | povidone 2 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441688 | Prothrombin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1441688 | Prothrombin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441688 | Prothrombin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1441688 | Prothrombin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441688 | Prothrombin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1441688 | Prothrombin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441689 | prothrombin, human | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1441729 | methyl salicylate 330 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1441730 | camphor 10 % / menthol 15 % / methyl salicylate 33 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441730 | camphor 10 % / menthol 15 % / methyl salicylate 33 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441730 | camphor 10 % / menthol 15 % / methyl salicylate 33 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1441735 | Duavee | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1441736 | bazedoxifene 20 MG / estrogens, conjugated (USP) 0.45 MG [Duavee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1441737 | bazedoxifene / estrogens, conjugated (USP) Oral Tablet [Duavee] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441738 | Duavee Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1441739 | Duavee Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1441740 | Duavee 0.45 MG / 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1441740 | Duavee 0.45 MG / 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1441740 | Duavee 0.45 MG / 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441743 | EDX-502 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1441744 | iodine 5 MG/ML [EDX-502] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1441745 | iodine Topical Solution [EDX-502] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1441746 | EDX-502 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1441747 | EDX-502 0.5 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1441747 | EDX-502 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441747 | EDX-502 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1441747 | EDX-502 0.5 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 144182 | Drug induced platelet antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144182 | Drug induced platelet antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1441826 | doxylamine succinate 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1441827 | doxylamine / phenylephrine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441828 | doxylamine / phenylephrine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1441829 | doxylamine / phenylephrine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1441830 | doxylamine / phenylephrine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1441831 | doxylamine succinate 7.5 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1441831 | doxylamine succinate 7.5 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 14419 | 3-hydroxykynurenine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14419 | 3-hydroxykynurenine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144190 | Antibody to ribonucleic acid polymerase I, II, and III | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144190 | Antibody to ribonucleic acid polymerase I, II, and III | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144194 | Rickettsia species antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144194 | Rickettsia species antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144195 | Typhus group rickettsia antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144195 | Typhus group rickettsia antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144196 | Antigen of Rubella virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144196 | Antigen of Rubella virus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144196 | Antigen of Rubella virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144196 | Antigen of Rubella virus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144198 | Salmonella Typhi group D, H antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144198 | Salmonella Typhi group D, H antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144199 | Salmonella Typhi group D, O antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144199 | Salmonella Typhi group D, O antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1442079 | sulfacetamide sodium 10 % / sulfur 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442079 | sulfacetamide sodium 10 % / sulfur 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442079 | sulfacetamide sodium 10 % / sulfur 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442079 | sulfacetamide sodium 10 % / sulfur 2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442080 | sulfacetamide sodium 95 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442081 | sulfacetamide sodium 9.5 % / sulfur 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442081 | sulfacetamide sodium 9.5 % / sulfur 5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442081 | sulfacetamide sodium 9.5 % / sulfur 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442081 | sulfacetamide sodium 9.5 % / sulfur 5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442082 | sulfacetamide sodium 95 MG/ML / sulfur 50 MG/ML [Avar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442083 | sulfacetamide / sulfur Medicated Pad [Avar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442084 | Avar Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442085 | Avar 9.5 % / 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442085 | Avar 9.5 % / 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442085 | Avar 9.5 % / 5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442085 | Avar 9.5 % / 5 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442087 | allantoin 0.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442087 | allantoin 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442087 | allantoin 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442088 | Mederma Advanced Scar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442089 | allantoin 0.005 MG/MG [Mederma Advanced Scar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442090 | allantoin Topical Gel [Mederma Advanced Scar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442091 | Mederma Advanced Scar Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442092 | Mederma Advanced Scar 0.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442092 | Mederma Advanced Scar 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442092 | Mederma Advanced Scar 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442092 | Mederma Advanced Scar 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442093 | afoxolaner | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442094 | afoxolaner 11.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1442095 | afoxolaner Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1442096 | afoxolaner Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1442097 | afoxolaner Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1442098 | afoxolaner Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1442099 | afoxolaner 11.3 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442099 | afoxolaner 11.3 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442100 | NexGard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442101 | afoxolaner 11.3 MG [NexGard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442102 | afoxolaner Chewable Tablet [NexGard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442103 | NexGard Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442104 | NexGard Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442105 | NexGard Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442106 | NexGard 11.3 MG for dogs 4-10 lbs. Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442106 | NexGard 11.3 MG for dogs 4-10 lbs. Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442106 | NexGard 11.3 MG for dogs 4-10 lbs. Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442107 | afoxolaner 136 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1442108 | afoxolaner 136 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442108 | afoxolaner 136 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442109 | afoxolaner 136 MG [NexGard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442110 | NexGard 136 MG for dogs 60.1-121 lbs. Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442110 | NexGard 136 MG for dogs 60.1-121 lbs. Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442110 | NexGard 136 MG for dogs 60.1-121 lbs. Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442111 | afoxolaner 28.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1442112 | afoxolaner 28.3 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442112 | afoxolaner 28.3 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442113 | afoxolaner 28.3 MG [NexGard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442114 | NexGard 28.3 MG for dogs 10.1-24 lbs.Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442114 | NexGard 28.3 MG for dogs 10.1-24 lbs.Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442114 | NexGard 28.3 MG for dogs 10.1-24 lbs.Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442115 | diclofenac 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442116 | diclofenac 18 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442116 | diclofenac 18 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442117 | Zorvolex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442118 | diclofenac 18 MG [Zorvolex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442119 | diclofenac Oral Capsule [Zorvolex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442120 | Zorvolex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442121 | Zorvolex Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442122 | Zorvolex 18 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442122 | Zorvolex 18 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442122 | Zorvolex 18 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442123 | afoxolaner 68 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1442124 | afoxolaner 68 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442124 | afoxolaner 68 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442125 | afoxolaner 68 MG [NexGard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442126 | NexGard 68 MG for dogs 24.1-60 lbs. Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442126 | NexGard 68 MG for dogs 24.1-60 lbs. Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442126 | NexGard 68 MG for dogs 24.1-60 lbs. Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442127 | diclofenac 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442128 | diclofenac 35 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442128 | diclofenac 35 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442129 | diclofenac 35 MG [Zorvolex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442130 | Zorvolex 35 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442130 | Zorvolex 35 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442130 | Zorvolex 35 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442132 | Macitentan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442132 | Macitentan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442132 | Macitentan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442132 | Macitentan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442132 | Macitentan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442133 | macitentan 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442134 | Macitentan-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1442134 | Macitentan-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442134 | Macitentan-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442135 | macitentan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1442136 | macitentan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1442137 | macitentan 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442137 | macitentan 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442137 | macitentan 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442137 | macitentan 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442138 | Opsumit | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442139 | macitentan 10 MG [Opsumit] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 144214 | Streptococcus pneumoniae 12 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144214 | Streptococcus pneumoniae 12 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144214 | Streptococcus pneumoniae 12 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1442140 | macitentan Oral Tablet [Opsumit] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442141 | Opsumit Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442142 | Opsumit Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442143 | Opsumit 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442143 | Opsumit 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442143 | Opsumit 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442145 | Avar LS 10 % / 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442145 | Avar LS 10 % / 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442145 | Avar LS 10 % / 2 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442146 | Next-1 antibacterial | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442147 | triclocarban 0.015 MG/MG [Next-1 antibacterial] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442148 | triclocarban Medicated Bar Soap [Next-1 antibacterial] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442149 | Next-1 antibacterial Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 144215 | Anti-Streptococcus pneumoniae Danish serotype 12F antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144215 | Anti-Streptococcus pneumoniae Danish serotype 12F antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144215 | Anti-Streptococcus pneumoniae Danish serotype 12F antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144215 | Anti-Streptococcus pneumoniae Danish serotype 12F antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144215 | Anti-Streptococcus pneumoniae Danish serotype 12F antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144215 | Anti-Streptococcus pneumoniae Danish serotype 12F antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144215 | Anti-Streptococcus pneumoniae Danish serotype 12F antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442150 | Next 1 Antibacterial 1.5 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442150 | Next 1 Antibacterial 1.5 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442150 | Next 1 Antibacterial 1.5 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442150 | Next 1 Antibacterial 1.5 % Medicated Bar Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442151 | Off! Explore | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442152 | benzocaine 50 MG/ML / camphor 30 MG/ML / phenol 13.5 MG/ML [Off! Explore] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442153 | benzocaine / camphor / phenol Topical Solution [Off! Explore] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442154 | Off! Explore Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442155 | OFF! Explore bite and itch relief 5 % / 3 % / 1.35 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442155 | OFF! Explore bite and itch relief 5 % / 3 % / 1.35 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442155 | OFF! Explore bite and itch relief 5 % / 3 % / 1.35 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442155 | OFF! Explore bite and itch relief 5 % / 3 % / 1.35 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442156 | Tab Tussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442157 | guaiFENesin 400 MG [Tab Tussin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442157 | guaiFENesin 400 MG [Tab Tussin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442158 | guaiFENesin Oral Tablet [Tab Tussin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442158 | guaiFENesin Oral Tablet [Tab Tussin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442159 | Tab Tussin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442160 | Tab Tussin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442161 | Tab Tussin 400 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442161 | Tab Tussin 400 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442161 | Tab Tussin 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442161 | Tab Tussin 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442162 | fenofibrate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442163 | fenofibrate 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442163 | fenofibrate 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442164 | fenofibrate 30 MG [Antara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442165 | Antara 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442165 | Antara 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442165 | Antara 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442167 | fenofibrate 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442168 | fenofibrate 90 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442168 | fenofibrate 90 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442169 | fenofibrate 90 MG [Antara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 144217 | Antibody to Streptococcus pneumoniae American serotype 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144217 | Antibody to Streptococcus pneumoniae American serotype 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144217 | Antibody to Streptococcus pneumoniae American serotype 56 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144217 | Antibody to Streptococcus pneumoniae American serotype 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144217 | Antibody to Streptococcus pneumoniae American serotype 56 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144217 | Antibody to Streptococcus pneumoniae American serotype 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144217 | Antibody to Streptococcus pneumoniae American serotype 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442170 | Antara 90 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442170 | Antara 90 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442170 | Antara 90 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442171 | bazedoxifene acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1442171 | bazedoxifene acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442171 | bazedoxifene acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442172 | enilconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 144218 | Streptococcus pneumoniae serogroup 19 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144218 | Streptococcus pneumoniae serogroup 19 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144218 | Streptococcus pneumoniae serogroup 19 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1442181 | ferrous bisglycinate 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1442182 | ferrous bisglycinate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1442183 | ferrous bisglycinate 90 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442183 | ferrous bisglycinate 90 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 144219 | Antibody to Streptococcus pneumoniae American serotype 19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144219 | Antibody to Streptococcus pneumoniae American serotype 19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144219 | Antibody to Streptococcus pneumoniae American serotype 19 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144219 | Antibody to Streptococcus pneumoniae American serotype 19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144219 | Antibody to Streptococcus pneumoniae American serotype 19 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144219 | Antibody to Streptococcus pneumoniae American serotype 19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144219 | Antibody to Streptococcus pneumoniae American serotype 19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442190 | beta-D-glucopyranose | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1442191 | Argemone mexicana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442192 | Aristolochia serpentaria root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442193 | Bos taurus eye preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442194 | influenza B virus vaccine, B-Massachusetts-2-2012-like virus, recombinant | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1442197 | octenyl succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442198 | Camellia sinensis var. assamica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442199 | lanosterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 144220 | Streptococcus pneumoniae 23 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144220 | Streptococcus pneumoniae 23 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144220 | Streptococcus pneumoniae 23 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1442200 | red yeast | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442200 | red yeast | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442201 | mevalonolactone, (+/-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1442202 | mevalonolactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442204 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1442205 | influenza virus vaccine 2014-2015 trivalent recombinant Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442205 | influenza virus vaccine 2014-2015 trivalent recombinant Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442206 | Flublok 2013-2014 Formula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442207 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Flublok 2013-2014 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442208 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution [Flublok 2013-2014 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442209 | Flublok 2013-2014 Formula Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 144221 | Antibody to Streptococcus pneumoniae American serotype 23 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144221 | Antibody to Streptococcus pneumoniae American serotype 23 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144221 | Antibody to Streptococcus pneumoniae American serotype 23 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144221 | Antibody to Streptococcus pneumoniae American serotype 23 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144221 | Antibody to Streptococcus pneumoniae American serotype 23 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144221 | Antibody to Streptococcus pneumoniae American serotype 23 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144221 | Antibody to Streptococcus pneumoniae American serotype 23 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442210 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2013-2014 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442210 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2013-2014 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442256 | Vetameg | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442257 | flunixin 50 MG/ML [Vetameg] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442258 | flunixin Injectable Solution [Vetameg] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442259 | Vetameg Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 144226 | Antibody to Streptococcus pneumoniae American serotype 26 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144226 | Antibody to Streptococcus pneumoniae American serotype 26 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144226 | Antibody to Streptococcus pneumoniae American serotype 26 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144226 | Antibody to Streptococcus pneumoniae American serotype 26 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144226 | Antibody to Streptococcus pneumoniae American serotype 26 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144226 | Antibody to Streptococcus pneumoniae American serotype 26 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144226 | Antibody to Streptococcus pneumoniae American serotype 26 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442260 | Vetameg 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442260 | Vetameg 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442260 | Vetameg 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442261 | menthol 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442261 | menthol 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442261 | menthol 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442262 | Melamin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442263 | hydroquinone 40 MG/ML [Melamin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442264 | hydroquinone Topical Cream [Melamin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442265 | Melamin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442266 | melamin 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442266 | melamin 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442266 | melamin 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442266 | melamin 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442266 | melamin 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442268 | Melamix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442269 | hydroquinone 40 MG/ML [Melamix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442270 | hydroquinone Topical Cream [Melamix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442271 | Melamix Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442272 | Melamix 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442272 | Melamix 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442272 | Melamix 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442272 | Melamix 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442274 | lidocaine 0.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442274 | lidocaine 0.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442274 | lidocaine 0.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442275 | Cebatrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442276 | salicylic acid 20 MG/ML [Cebatrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442277 | salicylic acid Medicated Pad [Cebatrol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442278 | Cebatrol Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442279 | Cebatrol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 144228 | Antibody to Streptococcus pneumoniae American serotype 51 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144228 | Antibody to Streptococcus pneumoniae American serotype 51 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144228 | Antibody to Streptococcus pneumoniae American serotype 51 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144228 | Antibody to Streptococcus pneumoniae American serotype 51 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144228 | Antibody to Streptococcus pneumoniae American serotype 51 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144228 | Antibody to Streptococcus pneumoniae American serotype 51 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144228 | Antibody to Streptococcus pneumoniae American serotype 51 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442280 | Cebatrol 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442280 | Cebatrol 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442280 | Cebatrol 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442280 | Cebatrol 2 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442281 | Aknetrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442282 | benzoyl peroxide 100 MG/ML [Aknetrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442283 | benzoyl peroxide Topical Lotion [Aknetrol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442284 | Aknetrol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442285 | Aknetrol 10 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442285 | Aknetrol 10 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442285 | Aknetrol 10 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442285 | Aknetrol 10 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 144230 | Antibody to Streptococcus pneumoniae American serotype 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144230 | Antibody to Streptococcus pneumoniae American serotype 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144230 | Antibody to Streptococcus pneumoniae American serotype 9 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144230 | Antibody to Streptococcus pneumoniae American serotype 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144230 | Antibody to Streptococcus pneumoniae American serotype 9 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144230 | Antibody to Streptococcus pneumoniae American serotype 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144230 | Antibody to Streptococcus pneumoniae American serotype 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144232 | Sulfate-3-glucuronyl paragloboside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144232 | Sulfate-3-glucuronyl paragloboside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144232 | Sulfate-3-glucuronyl paragloboside antibody | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144238 | Anti-tetrasialylganglioside GQ1b antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144238 | Anti-tetrasialylganglioside GQ1b antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144240 | Thermoactinomyces species antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144240 | Thermoactinomyces species antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1442401 | Keralyt 5 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442402 | salicylic acid 0.05 MG/MG [Keralyt 5] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442403 | salicylic acid Topical Gel [Keralyt 5] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442404 | Keralyt 5 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442405 | Keralyt 5, 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442405 | Keralyt 5, 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442405 | Keralyt 5, 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442405 | Keralyt 5, 5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442407 | camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442407 | camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442407 | camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442414 | heparin sodium, porcine 600 UNT per 6 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442414 | heparin sodium, porcine 600 UNT per 6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442442 | calcium 600 MG / vitamin D3 800 UNT Chewable Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442442 | calcium 600 MG / vitamin D3 800 UNT Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442442 | calcium 600 MG / vitamin D3 800 UNT Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442442 | calcium 600 MG / vitamin D3 800 UNT Chewable Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442443 | Caltrate 600 + D 600 MG / 800 UNT Chewable Tablet, as calcium carbonate | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442443 | Caltrate 600 + D 600 MG / 800 UNT Chewable Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442443 | Caltrate 600 + D 600 MG / 800 UNT Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442443 | Caltrate 600 + D 600 MG / 800 UNT Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442444 | acetaminophen 20 MG/ML / hydrocodone bitartrate 0.667 MG/ML [Lortab] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442444 | acetaminophen 20 MG/ML / hydrocodone bitartrate 0.667 MG/ML [Lortab] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442445 | LORTAB 10 MG / 300 MG in 15 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442445 | LORTAB 10 MG / 300 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442445 | LORTAB 10 MG / 300 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442445 | LORTAB 10 MG / 300 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442445 | LORTAB 10 MG / 300 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442445 | LORTAB 10 MG / 300 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442445 | LORTAB 10 MG / 300 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442504 | Azadirachta indica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442505 | Cupressus sempervirens leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442506 | Cymbopogon flexuosus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442507 | Cymbopogon martini top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442508 | Daucus carota subsp. sativus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442509 | Litsea cubeba fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442510 | white pepper oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442511 | Salvia officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442512 | Pelargonium graveolens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442513 | menthol 5 % / methyl salicylate 0.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442513 | menthol 5 % / methyl salicylate 0.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442513 | menthol 5 % / methyl salicylate 0.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442514 | crinis carbonisatus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442514 | crinis carbonisatus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442516 | ammonium laurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1442517 | polyquaternium-22 (4500 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442519 | salicylic acid 50 MG/ML [Keralyt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442520 | Keralyt 5 5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442520 | Keralyt 5 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442520 | Keralyt 5 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442520 | Keralyt 5 5 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442521 | HYDROcodone Extended Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1442521 | HYDROcodone Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442522 | hydrocodone bitartrate 10 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442522 | hydrocodone bitartrate 10 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442523 | Zohydro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442524 | hydrocodone bitartrate 10 MG [Zohydro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442524 | hydrocodone bitartrate 10 MG [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442525 | HYDROcodone Extended Release Oral Capsule [Zohydro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442525 | HYDROcodone Extended Release Oral Capsule [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442526 | Zohydro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442527 | Zohydro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442528 | hydrocodone bitartrate 10 MG Extended Release Oral Capsule [Zohydro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442528 | hydrocodone bitartrate 10 MG Extended Release Oral Capsule [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442528 | hydrocodone bitartrate 10 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442528 | hydrocodone bitartrate 10 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442529 | hydrocodone bitartrate 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442529 | hydrocodone bitartrate 15 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442530 | hydrocodone bitartrate 15 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442530 | hydrocodone bitartrate 15 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442531 | hydrocodone bitartrate 15 MG [Zohydro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442531 | hydrocodone bitartrate 15 MG [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442532 | hydrocodone bitartrate 15 MG Extended Release Oral Capsule [Zohydro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442532 | hydrocodone bitartrate 15 MG Extended Release Oral Capsule [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442532 | hydrocodone bitartrate 15 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442532 | hydrocodone bitartrate 15 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442533 | hydrocodone bitartrate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442533 | hydrocodone bitartrate 20 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442534 | hydrocodone bitartrate 20 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442534 | hydrocodone bitartrate 20 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442535 | hydrocodone bitartrate 20 MG [Zohydro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442535 | hydrocodone bitartrate 20 MG [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442536 | hydrocodone bitartrate 20 MG Extended Release Oral Capsule [Zohydro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442536 | hydrocodone bitartrate 20 MG Extended Release Oral Capsule [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442536 | hydrocodone bitartrate 20 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442536 | hydrocodone bitartrate 20 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442537 | hydrocodone bitartrate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442537 | hydrocodone bitartrate 30 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442538 | hydrocodone bitartrate 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442538 | hydrocodone bitartrate 30 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442539 | hydrocodone bitartrate 30 MG [Zohydro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442539 | hydrocodone bitartrate 30 MG [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 144254 | Lortab | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442540 | hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442540 | hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442540 | hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442540 | hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442541 | hydrocodone bitartrate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442541 | hydrocodone bitartrate 40 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442542 | hydrocodone bitartrate 40 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442542 | hydrocodone bitartrate 40 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442543 | hydrocodone bitartrate 40 MG [Zohydro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442543 | hydrocodone bitartrate 40 MG [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442544 | hydrocodone bitartrate 40 MG Extended Release Oral Capsule [Zohydro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442544 | hydrocodone bitartrate 40 MG Extended Release Oral Capsule [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442544 | hydrocodone bitartrate 40 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442544 | hydrocodone bitartrate 40 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442545 | hydrocodone bitartrate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442545 | hydrocodone bitartrate 50 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442546 | hydrocodone bitartrate 50 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442546 | hydrocodone bitartrate 50 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442547 | hydrocodone bitartrate 50 MG [Zohydro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442547 | hydrocodone bitartrate 50 MG [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1442548 | hydrocodone bitartrate 50 MG Extended Release Oral Capsule [Zohydro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442548 | hydrocodone bitartrate 50 MG Extended Release Oral Capsule [Zohydro] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1442548 | hydrocodone bitartrate 50 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442548 | hydrocodone bitartrate 50 MG Extended Release Oral Capsule [Zohydro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442571 | EDX-1000 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442572 | iodine 10 MG/ML [EDX-1000] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442573 | iodine Topical Solution [EDX-1000] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442574 | EDX-1000 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442575 | EDX-1000 1 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442575 | EDX-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442575 | EDX-1000 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442575 | EDX-1000 1 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442576 | EDX-102 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442577 | iodine 10 MG/ML [EDX-102] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442578 | iodine Topical Solution [EDX-102] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442579 | EDX-102 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442580 | EDX-102 1 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442580 | EDX-102 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442580 | EDX-102 1 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442580 | EDX-102 1 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442581 | iodine 5 MG/ML [EDX-1000] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442582 | Udder 330 Iodine Udder Wash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442582 | Udder 330 Iodine Udder Wash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442582 | Udder 330 Iodine Udder Wash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442582 | Udder 330 Iodine Udder Wash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442582 | Udder 330 Iodine Udder Wash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442584 | econazole Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1442585 | econazole nitrate 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442585 | econazole nitrate 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442585 | econazole nitrate 1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442586 | Ecoza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442587 | econazole nitrate 10 MG/ML [Ecoza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442588 | econazole Topical Foam [Ecoza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442589 | Ecoza Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442590 | ecoza 1 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442590 | ecoza 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442590 | ecoza 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442590 | ecoza 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442601 | PulmoSal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442604 | PulmoSal Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442675 | acepromazine maleate 10 MG [PROMACE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442676 | PromAce Tablets 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442676 | PromAce Tablets 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442676 | PromAce Tablets 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442677 | Granix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442678 | tbo-filgrastim 0.6 MG/ML [Granix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442679 | filgrastim Prefilled Syringe [Granix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442680 | Granix Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442681 | Granix 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442681 | Granix 300 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442681 | Granix 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442681 | Granix 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442682 | tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442682 | tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442683 | Granix 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442683 | Granix 480 MCG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442683 | Granix 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442683 | Granix 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442684 | menthol Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1442685 | menthol 3.5 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442685 | menthol 3.5 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442685 | menthol 3.5 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442686 | menthol 2.5 % / methyl salicylate 12.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442686 | menthol 2.5 % / methyl salicylate 12.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442687 | menthol 25 MG/ML / methyl salicylate 125 MG/ML [Artrosamin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442688 | Artosamin (menthol 2.5 % / methyl salicylate 12.5 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442688 | Artosamin (menthol 2.5 % / methyl salicylate 12.5 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442688 | Artosamin (menthol 2.5 % / methyl salicylate 12.5 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442690 | obinutuzumab 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442691 | obinutuzumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1442691 | obinutuzumab Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442691 | obinutuzumab Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442693 | obinutuzumab 1000 MG in 40 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442693 | obinutuzumab 1000 MG in 40 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442693 | obinutuzumab 1000 MG in 40 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442694 | Gazyva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442695 | obinutuzumab 25 MG/ML [Gazyva] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442697 | Gazyva Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442698 | Gazyva 1000 MG in 40 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442698 | Gazyva 1000 MG in 40 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442698 | Gazyva 1000 MG in 40 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442699 | Melilotus indicus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442700 | Prunus virginiana bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442701 | Commiphora myrrha whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442702 | Dictamnus dasycarpus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442703 | Gleditsia sinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442704 | Rheum palmatum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442705 | Sanguisorba officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442706 | Sophora flavescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442707 | hydroxypropyl-alpha-cyclodextrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442708 | natural red 26 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442710 | Zit Stick | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442711 | salicylic acid 20 MG/ML [Zit Stick] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442712 | salicylic acid Topical Cream [Zit Stick] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442713 | Zit Stick Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442714 | Zit Stick 2 % Topical Stick | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442714 | Zit Stick 2 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442714 | Zit Stick 2 % Topical Stick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442714 | Zit Stick 2 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442714 | Zit Stick 2 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442717 | sodium 1-naphthalenesulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1442718 | 1-naphthalenesulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442719 | Eucerin Eczema Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442720 | colloidal oatmeal 10 MG/ML [Eucerin Eczema Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442721 | colloidal oatmeal Topical Cream [Eucerin Eczema Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442722 | Eucerin Eczema Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442723 | Eucerin Eczema Relief 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442723 | Eucerin Eczema Relief 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442723 | Eucerin Eczema Relief 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442723 | Eucerin Eczema Relief 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442787 | menthol 25 MG/ML / methyl salicylate 125 MG/ML [Reumacetin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442788 | Reumacetin (menthol 2.5 % / methyl salicylate 12.5 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442788 | Reumacetin (menthol 2.5 % / methyl salicylate 12.5 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442788 | Reumacetin (menthol 2.5 % / methyl salicylate 12.5 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442790 | morphine sulfate 5 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442790 | morphine sulfate 5 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442790 | morphine sulfate 5 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442790 | morphine sulfate 5 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442791 | Bos taurus intervertebral disc preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442792 | Stachys officinalis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442844 | Dermasorb AF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442845 | clioquinol 30 MG/ML / hydrocortisone 5 MG/ML [Dermasorb AF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442846 | clioquinol / hydrocortisone Topical Cream [Dermasorb AF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442847 | Dermasorb AF Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442848 | Dermasorb AF 0.5 % / 3 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442848 | Dermasorb AF 0.5 % / 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442848 | Dermasorb AF 0.5 % / 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442849 | petrolatum 30 % / zinc oxide 20 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442849 | petrolatum 30 % / zinc oxide 20 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442849 | petrolatum 30 % / zinc oxide 20 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442849 | petrolatum 30 % / zinc oxide 20 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442850 | Dermagran BC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442851 | petrolatum 0.3 MG/MG / zinc oxide 0.2 MG/MG [Dermagran BC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442852 | petrolatum / zinc oxide Topical Ointment [Dermagran BC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442853 | Dermagran BC Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442854 | DERMA GRAN BC 20 % / 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442854 | DERMA GRAN BC 20 % / 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442854 | DERMA GRAN BC 20 % / 30 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442854 | DERMA GRAN BC 20 % / 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442855 | petrolatum 0.85 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442856 | petrolatum 85 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1442856 | petrolatum 85 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442856 | petrolatum 85 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442857 | Dermagran GP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442858 | petrolatum 0.85 MG/MG [Dermagran GP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442859 | petrolatum Topical Ointment [Dermagran GP] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442860 | Dermagran GP Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442861 | DERMA GRAN GP 85 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442861 | DERMA GRAN GP 85 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442861 | DERMA GRAN GP 85 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442861 | DERMA GRAN GP 85 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442867 | Dermasorb HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442868 | hydrocortisone 20 MG/ML [Dermasorb HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442869 | hydrocortisone Topical Lotion [Dermasorb HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442870 | Dermasorb HC Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442871 | Dermasorb HC 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442871 | Dermasorb HC 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442871 | Dermasorb HC 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442871 | Dermasorb HC 2 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442872 | Dermasorb TA | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442873 | triamcinolone acetonide 1 MG/ML [Dermasorb TA] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442874 | triamcinolone Topical Cream [Dermasorb TA] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442875 | Dermasorb TA Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442876 | Dermasorb TA 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442876 | Dermasorb TA 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442876 | Dermasorb TA 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442876 | Dermasorb TA 0.1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442877 | Dermasorb XM | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442878 | urea 390 MG/ML [Dermasorb XM] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442879 | urea Topical Cream [Dermasorb XM] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442880 | Dermasorb XM Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442881 | Dermasorb XM 39 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442881 | Dermasorb XM 39 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442881 | Dermasorb XM 39 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442881 | Dermasorb XM 39 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442882 | Cervus nippon velvet preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442883 | olealkonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442960 | Servo Stat Bac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442961 | benzalkonium chloride 1 MG/ML [Servo Stat Bac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442962 | benzalkonium Topical Foam [Servo Stat Bac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442963 | Servo Stat Bac Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442964 | SERVO STAT BAC 0.1 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442964 | SERVO STAT BAC 0.1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442964 | SERVO STAT BAC 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442964 | SERVO STAT BAC 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442966 | Clearasil Ultra Rapid Action | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442967 | salicylic acid 20 MG/ML [Clearasil Ultra Rapid Action] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442968 | salicylic acid Topical Lotion [Clearasil Ultra Rapid Action] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442969 | Clearasil Ultra Rapid Action Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442970 | Clearasil Ultra Rapid Action 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442970 | Clearasil Ultra Rapid Action 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442970 | Clearasil Ultra Rapid Action 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442970 | Clearasil Ultra Rapid Action 2 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442971 | Salic-2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1442972 | salicylic acid 20 MG/ML [Salic-2] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1442973 | salicylic acid Medicated Liquid Soap [Salic-2] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442974 | Salic-2 Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1442975 | Salic-2 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1442975 | Salic-2 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442975 | Salic-2 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1442975 | Salic-2 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1442976 | Mederma PM | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442977 | dimethicone 20 MG/ML [Mederma PM] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442978 | dimethicone Topical Cream [Mederma PM] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442979 | Mederma PM Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442980 | Mederma PM 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442980 | Mederma PM 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442980 | Mederma PM 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442980 | Mederma PM 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442980 | Mederma PM 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442981 | Ibrutinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1442981 | Ibrutinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442981 | Ibrutinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442981 | Ibrutinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442981 | Ibrutinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442982 | ibrutinib 140 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1442983 | Ibrutinib-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1442983 | Ibrutinib-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442983 | Ibrutinib-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442984 | ibrutinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1442985 | ibrutinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1442986 | ibrutinib 140 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442986 | ibrutinib 140 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1442986 | ibrutinib 140 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1442986 | ibrutinib 140 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1442987 | Imbruvica | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1442988 | ibrutinib 140 MG [Imbruvica] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1442989 | ibrutinib Oral Capsule [Imbruvica] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442990 | Imbruvica Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442991 | Imbruvica Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1442992 | Imbruvica 140 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1442992 | Imbruvica 140 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1442992 | Imbruvica 140 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1442993 | Hyoscyamus niger whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442994 | Potentilla anserina whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442995 | Prunus spinosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442996 | thyroid, ovine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442997 | Dictyopteris polypodioides extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442998 | cetyl dimethicone 150 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1442999 | calcium picrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1443000 | picrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1443001 | sodium dithionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1443002 | dithionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1443044 | Quinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1443044 | Quinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1443044 | Quinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1443044 | Quinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1443044 | Quinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1443044 | Quinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1443513 | Substance with sulfonamide structure and antibacterial mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1443513 | Substance with sulfonamide structure and antibacterial mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1443513 | Substance with sulfonamide structure and antibacterial mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1443513 | Substance with sulfonamide structure and antibacterial mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1443513 | Substance with sulfonamide structure and antibacterial mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144375 | D-usnic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144375 | D-usnic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144375 | D-usnic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144375 | D-usnic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144376 | Cresylglycidyl ether | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144376 | Cresylglycidyl ether | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144376 | Cresylglycidyl ether | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144376 | Cresylglycidyl ether | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144377 | Arnica extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144377 | Arnica extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144377 | Arnica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 144377 | Arnica extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144377 | Arnica extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144377 | Arnica extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144377 | Arnica extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144381 | Oil and cooling fluid patch test series | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144381 | Oil and cooling fluid patch test series | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144383 | Perfumes and flavors patch test series | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144383 | Perfumes and flavors patch test series | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144383 | Perfumes and flavors patch test series | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 144384 | Everninic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144384 | Everninic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144384 | Everninic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144384 | Everninic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144436 | Folic acid supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144436 | Folic acid supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144450 | DHA - Docosahexaenoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 144450 | DHA - Docosahexaenoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 144450 | DHA - Docosahexaenoic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 144450 | DHA - Docosahexaenoic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1444658 | Substance with 5-alpha reductase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1444658 | Substance with 5-alpha reductase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1444658 | Substance with 5-alpha reductase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1444658 | Substance with 5-alpha reductase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1444658 | Substance with 5-alpha reductase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144472 | Methylated spirit | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144472 | Methylated spirit | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144475 | Aftershave | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144475 | Aftershave | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144479 | Marijuana oil | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144479 | Marijuana oil | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144479 | Marijuana oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 14448 | Metaiodobenzylguanidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 14448 | Metaiodobenzylguanidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 14448 | Metaiodobenzylguanidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 14448 | Metaiodobenzylguanidine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 14448 | Metaiodobenzylguanidine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1444851 | Substance with ganglion blocking mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1444851 | Substance with ganglion blocking mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1444851 | Substance with ganglion blocking mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1444851 | Substance with ganglion blocking mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1444851 | Substance with ganglion blocking mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1444868 | Calcium supplement | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1444868 | Calcium supplement | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1444874 | Sodium supplement | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1444874 | Sodium supplement | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144496 | Plant matter | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144496 | Plant matter | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144496 | Plant matter | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144496 | Plant matter | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144496 | Plant matter | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1445143 | Ipratropium bromide anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1445143 | Ipratropium bromide anhydrous | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1445143 | Ipratropium bromide anhydrous | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 14454 | 3-isopropylmalate dehydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14454 | 3-isopropylmalate dehydratase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 14455 | 3-isopropylmalate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14455 | 3-isopropylmalate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144557 | Calcium supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144557 | Calcium supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144558 | Medicinal product acting as sodium supplement (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144558 | Medicinal product acting as sodium supplement (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144575 | Seed mixture | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144575 | Seed mixture | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1445798 | Phytochemical | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1445798 | Phytochemical | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1445798 | Phytochemical | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1445798 | Phytochemical | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 14462 | 3-oxoacid coenzyme A-transferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14462 | 3-oxoacid coenzyme A-transferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 14462 | 3-oxoacid coenzyme A-transferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144634 | Hornet venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144634 | Hornet venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144639 | Bumble bee venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144639 | Bumble bee venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144644 | Magic mushrooms | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144644 | Magic mushrooms | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144644 | Magic mushrooms | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 144659 | Cedar pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144659 | Cedar pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144660 | Elder pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144660 | Elder pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144661 | Cypress pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144661 | Cypress pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144662 | Juniper pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144662 | Juniper pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144663 | Lime pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144663 | Lime pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144664 | Palm pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144664 | Palm pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144665 | Fungal material | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144665 | Fungal material | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144666 | Organic natural material | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144666 | Organic natural material | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144673 | Potassium dicyanoaurate (in water) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144673 | Potassium dicyanoaurate (in water) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 144673 | Potassium dicyanoaurate (in water) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1446906 | Product containing teneligliptin (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1446906 | Product containing teneligliptin (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1446906 | Product containing teneligliptin (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1446906 | Product containing teneligliptin (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144692 | Animal bone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 144692 | Animal bone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1447074 | Vermouth | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1447074 | Vermouth | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 14474 | 3-mercaptopyruvate sulfurtransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14474 | 3-mercaptopyruvate sulfurtransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 14474 | 3-mercaptopyruvate sulfurtransferase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1448 | Beta-2 microglobulin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1448 | Beta-2 microglobulin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1448 | Beta-2 microglobulin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1448 | Beta-2 microglobulin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 14485 | 3-O-methyldopa | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 14485 | 3-O-methyldopa | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1449 | Beta-2 transferrin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1449 | Beta-2 transferrin | Full form of descriptor (FN) | NO |